Seer 

Yahoo Finance • 11 hours ago

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

REDWOOD CITY, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the upcoming American Society of Human Genetic... Full story

Yahoo Finance • last month

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Morgan Stanl... Full story

Yahoo Finance • 2 months ago

Seer reiterates $17M–$18M revenue target for 2025 amid macro headwinds and new Proteograph ONE launch

Earnings Call Insights: Seer, Inc. (SEER) Q2 2025 MANAGEMENT VIEW * Omid C. Farokhzad, Founder, CEO & Chair of the Board, stated Q2 2025 was a pivotal quarter with "discipline, advance key commercial and product milestones and accelera... Full story

Yahoo Finance • 2 months ago

Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference

REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Canaccord Ge... Full story

Yahoo Finance • 3 months ago

Seer to Report Second Quarter 2025 Financial Results on August 6, 2025

REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 o... Full story

Yahoo Finance • 4 months ago

Seer director Nishar Dipchand sells shares worth $62,935

Nishar Dipchand, a director at Seer, Inc. (NASDAQ:SEER), recently sold 30,253 shares of the company’s Class A common stock. The sale, completed on June 13, 2025, was executed under a Rule 10b5-1 trading plan, which had been adopted by Dipc... Full story

Yahoo Finance • 4 months ago

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults

First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay to accelerate analysis and reduce cost... Full story

Yahoo Finance • 4 months ago

Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency

REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteograph® Product Suite, featuring the Prot... Full story

Yahoo Finance • 5 months ago

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

REDWOOD CITY, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the first quarter ended Marc... Full story

Yahoo Finance • 8 months ago

Seer to Participate in the TD Cowen 45th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the up... Full story

Yahoo Finance • 8 months ago

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025

REDWOOD CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will showcase new findings at t... Full story

Yahoo Finance • 8 months ago

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the fo... Full story

Yahoo Finance • 2 years ago

Need To Know: The Consensus Just Cut Its Seer, Inc. (NASDAQ:SEER) Estimates For 2024

One thing we could say about the analysts on Seer, Inc. (NASDAQ:SEER) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. Revenue estimates were cut sharply as... Full story

Yahoo Finance • 2 years ago

Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the... Full story

Yahoo Finance • 2 years ago

Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500

REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company was selected as “Proteomics Sol... Full story

Yahoo Finance • 2 years ago

Seer Inc (SEER) Reports Modest Revenue Growth Amidst Economic Headwinds

Seer Inc (NASDAQ:SEER) reports a 5% year-over-year revenue increase to $4.2 million in Q3 2023. Gross margin stands at 52%, with a net loss of $21.1 million, marking an improvement from the previous year. Company ends quarter with a strong... Full story

Yahoo Finance • 2 years ago

Seer Reports Third Quarter 2023 Financial Results

REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the third quarter ended September 3... Full story

Yahoo Finance • 2 years ago

Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program

REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that Panome Bio has joined its COE Program. Panome Bio is... Full story

Yahoo Finance • 2 years ago

Seer to Report Third Quarter 2023 Financial Results on November 7, 2023

REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the third quar... Full story

Yahoo Finance • 2 years ago

Seer to Participate in Upcoming September Investor Conferences

REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company management will be participating in the followi... Full story